SCHEMBL27299490

SCHEMBL27299490

Cc1ccc(OCc2csc(C)n2)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
SLC6A4 P31645 1/20 0.54
HTR2B P41595 1/20 0.54
POLB P06746 2/20 0.47
MRGPRX4 Q96LA9 1/20 0.46
EPHA2 P29317 1/20 0.46
KDR P35968 1/20 0.46
EPHB4 P54760 1/20 0.46
RAB9A P51151 4/20 0.43
NPC1 O15118 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NMT1 P30419 1/20 0.43
MAPT P10636 5/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
ATM Q13315 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPK1 P28482 2/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27096948 0.86 HTR2A (0.52) HTR2AHTR2CSLC6A4HTR2BPOLB
SCHEMBL30729931 0.86 HTR2A (0.52) HTR2AHTR2CSLC6A4HTR2BPOLB
SCHEMBL27096888 0.81 MAPT (0.48) HTR2AHTR2CSLC6A4HTR2BPOLB
SCHEMBL27299484 0.77 RAB9A (0.46) POLBMRGPRX4RAB9ANPC1SMN1; SMN2
SCHEMBL10227870 0.75 MRGPRX4 (0.53) MRGPRX4RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL12524878 0.75 MRGPRX4 (0.50) POLBMRGPRX4RAB9ANPC1SMN1; SMN2
SCHEMBL7861771 0.75 SMN1; SMN2 (0.71) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL14777185 0.74 FFAR1 (0.50) HTR2AHTR2CSLC6A4HTR2BPOLB
SCHEMBL2760112 0.74 SYK (0.59) SLC6A4MRGPRX4RAB9ANPC1SMN1; SMN2
SCHEMBL11911910 0.73 HTR2A (0.50) HTR2AHTR2CSLC6A4HTR2BPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026056-A2 HETEROARYL COMPOUNDS AS EGFR INHIBITORS AND THEIR USES ACCUTAR BIOTECHNOLOGY, INC. (US) 2024-02-01 WO disclosed